Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Polyzos, S. A., & Kountouras J. (2013).  Serum alpha-fetoprotein in patients with nonalcoholic fatty liver disease.. Eur Rev Med Pharmacol Sci. 17(17), 2411-2.
Polyzos, S. A., Kountouras J., & Zavos C. (2009).  Insulin resistance and therapy: cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways.. Med Hypotheses. 72(5), 610.
Polyzos, S. A., Toulis K. A., Goulis D. G., Zavos C., & Kountouras J. (2011).  Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.. Metabolism. 60(3), 313-26.
Polyzos, S. A., Perakakis N., & Mantzoros C. S. (2019).  Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.. Metabolism. 96, 66-82.
Polyzos, S. A., Kountouras J., Papatheodorou A., Katsiki E., Patsiaoura K., Zafeiriadou E., et al. (2013).  Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.. Ann Hepatol. 12(5), 749-57.
Polyzos, S. A., & Anastasilakis A. D. (2016).  Periostin on the road to nonalcoholic fatty liver disease.. Endocrine. 51(1), 4-6.
Polyzos, N. P., Fatemi H. M., Zavos A., Grimbizis G., Kyrou D., Velasco J-G., et al. (2011).  Aromatase inhibitors in post-menopausal endometriosis.. Reprod Biol Endocrinol. 9, 90.
Polyzos, S. Alexandros, Kountouras J., & Zavos C. (2010).  Nonlinear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis.. J Clin Gastroenterol. 44(3), 229-30; author reply 230-1.
Polyzos, S. A., Kita M., Efstathiadou Z., Goulis D. G., Benos A., Flaris N., et al. (2009).  The use of demographic, ultrasonographic and scintigraphic data in the diagnostic approach of thyroid nodules.. Exp Clin Endocrinol Diabetes. 117(4), 159-64.
Polyzos, S. A., Slavakis A., Koumerkeridis G., Katsinelos P., & Kountouras J. (2019).  Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.. Horm Metab Res. 51(2), 134-140.
Polyzos, S. A., & Kountouras J. (2019).  Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy.. Helicobacter. 24(3), e12588.
Polyzos, S. A., & Mantzoros C. S. (2015).  Leptin in health and disease: facts and expectations at its twentieth anniversary.. Metabolism. 64(1), 5-12.
Polyzos, S. A., & Mantzoros C. S. (2024).  Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management.. Metabolism. 155936.
Polyzos, S. A., Kountouras J., Polymerou V., Papadimitriou K. G., Zavos C., & Katsinelos P. (2016).   Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease.. Ann Hepatol. 15(5), 705-14.
Polyzos, S. A., Frühbeck G., & Kiortsis D. N. (2023).  Peptide Polyagonists for the Treatment of Nonalcoholic Fatty Liver Disease.. Curr Pharm Des. 29(41), 3263-3265.
Polyzos, S. A., & Anastasilakis A. D. (2010).  Systematic review of cases reporting blood extravasation-related complications after thyroid fine-needle biopsy.. J Otolaryngol Head Neck Surg. 39(5), 532-41.
Polyzos, S. A., Perakakis N., Boutari C., Kountouras J., Ghaly W., Anastasilakis A. D., et al. (2019).  Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD.. J Clin Endocrinol Metab.
Polyzos, S. A., Kita M., Goulis D. G., Benos A., Flaris N., Leontsini M., et al. (2008).  Epidemiologic analysis of thyroid fine needle aspiration biopsies over a period of 18 years (1987-2004).. Exp Clin Endocrinol Diabetes. 116(8), 496-500.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2017).  Adipose tissue, obesity and non-alcoholic fatty liver disease.. Minerva Endocrinol. 42(2), 92-108.
Polyzos, S. A., Kountouras J., Tsatsoulis A., Zafeiriadou E., Katsiki E., Patsiaoura K., et al. (2013).  Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease.. Hormones (Athens). 12(3), 405-16.
Polyzos, S. A., Goulis D. G., Kountouras J., Mintziori G., Chatzis P., Papadakis E., et al. (2014).  Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.. Hormones (Athens). 13(4), 519-31.
Polyzos, S. A., Kountouras J., Slavakis A., Zafeiriadou E., Patsiaoura K., Katsiki E., et al. (2013).  A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study.. Biomarkers. 18(7), 607-13.
Polyzos, S. A., Anastasilakis A. D., Efstathiadou Z., Kita M., Litsas I., Avramidis A., et al. (2009).  The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone.. Horm Metab Res. 41(11), 846-50.
Polyzos, S. A., & Anastasilakis A. D. (2009).  Clinical complications following thyroid fine-needle biopsy: a systematic review.. Clin Endocrinol (Oxf). 71(2), 157-65.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2011).  Helicobacter pylori and insulin resistance association: not just a myth, not yet a fact.. Saudi J Gastroenterol. 17(6), 425-6.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.